Back to AKRO

Akero Therapeutics, Inc. 8-K

Accession 0001193125-24-135733

Filing information

CIK
0001744659
Report date
2024-05-10
Filing date
2024-05-10
Form
8-K
Primary document
d836734d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.